Harrow (HROW) Goodwill (2014 - 2026)
Harrow (HROW) posted quarterly Goodwill of $332000.0 for Q4 2025, little changed year-over-year from $332000.0 in Q4 2024, and little changed quarter-over-quarter from $332000.0 in Q3 2025.
Harrow (HROW) Goodwill (2014 - 2026) Analysis & Trends
Harrow's Goodwill history runs 12 years deep, the most recent figure standing at $332000.0 for Q4 2025.
- In Q4 2025, Goodwill changed 0.0% year-over-year to $332000.0; the TTM figure through Dec 2025 stood at $332000.0 (changed 0.0% YoY), while the FY2025 annual figure was $332000.0, changed 0.0% from the prior year.
- Goodwill for Q4 2025 stood at $332000.0, roughly flat from $332000.0 in the prior quarter.
- The five-year high for Goodwill was $332000.0 in Q1 2021, with the low at $332000.0 in Q1 2021.
- The 5-year median for Goodwill is $332000.0 (2021), against an average of $332000.0.
- Peak annual rise in Goodwill reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
- Harrow's Goodwill stood at $332000.0 in 2021, then changed by 0.0% to $332000.0 in 2022, then changed by 0.0% to $332000.0 in 2023, then changed by 0.0% to $332000.0 in 2024, then changed by 0.0% to $332000.0 in 2025.
- Business Quant data shows HROW's Goodwill at $332000.0 in Q4 2025, $332000.0 in Q3 2025, and $332000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Harrow | 1.59 Bn | 1.51 Bn | 50.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 332,000.00 |
| Mar 31, 2026 | 332,000.00 |
| Dec 31, 2025 | 332,000.00 |
| Sep 30, 2025 | 332,000.00 |
| Dec 31, 2024 | 332,000.00 |
| Mar 31, 2023 | 332,000.00 |
| Dec 31, 2022 | 332,000.00 |
| Sep 30, 2022 | 332,000.00 |
| Jun 30, 2022 | 332,000.00 |
| Mar 31, 2022 | 332,000.00 |
| Dec 31, 2021 | 332,000.00 |
| Sep 30, 2021 | 332,000.00 |
| Jun 30, 2021 | 332,000.00 |
| Mar 31, 2021 | 332,000.00 |
| Dec 31, 2020 | 332,000.00 |
| Sep 30, 2020 | 332,000.00 |
| Jun 30, 2020 | 332,000.00 |
| Mar 31, 2020 | 332,000.00 |
| Dec 31, 2019 | 332,000.00 |
| Sep 30, 2019 | 332,000.00 |